Dr. Samuel A. Merrill

Enrico M. Novelli, MD, is a classical (benign) hematologist, the Chief of the Section of Benign Hematology, and the medical director of the UPMC Adult Sickle Cell Disease Program. Board-certified in hematology, Dr. Novelli received his medical degree from the University of Milan, Italy. He completed his residency in internal medicine and fellowship in hematology-oncology at UPMC. Dr. Novelli specializes in sickle cell anemia and hemoglobinopathies. Dr. Novelli is rated as a Distinguished provider by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Laura M. De Castro MD, MHSc, is an associate professor of medicine, director of benign hematology for the Institute for Transfusion Medicine and UPMC Hillman Cancer Center, and director of clinical translational research for the Sickle Cell Disease Research Center of Excellence. In addition, she is a hematologist specializing in sickle cell disease and other hemoglobinopathies. Dr. De Castro also serves as clinical director of the benign hematology program at UPMC, and works to expand clinical programs in hemostasis and thrombosis. Dr. Castro is rated as an Advanced provider by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. Her top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobin E Disease, and Hemoglobin C Disease.

Robert Kaplan is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of D-Minus Hemolytic Uremic Syndrome. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Deep Vein Thrombosis.